Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Focal adhesion kinase 1 (FAK), encoded by the PTK2 gene, is a cytoplasmic non-receptor protein-tyrosine kinase that plays a central role in integrating extracellular signals from integrins and growth factor receptors. It regulates key cellular processes including cell adhesion, migration, survival, proliferation, and angiogenesis. FAK functions through both its kinase-dependent catalytic activity and its kinase-independent scaffolding roles, which coordinate the assembly of focal adhesion complexes and downstream signaling pathways such as PI3K/Akt and MAPK/ERK.\n\nIn pathological contexts, FAK is frequently overexpressed and hyperactivated in various solid tumors, where it promotes tumor progression, metastasis, chemoresistance, and the establishment of an immunosuppressive tumor microenvironment. Consequently, FAK has emerged as a promising therapeutic target in oncology. Small-molecule FAK inhibitors, such as defactinib and ifebemtinib, primarily act as ATP-competitive inhibitors that block FAK autophosphorylation at tyrosine 397, thereby disrupting downstream signaling. Additionally, novel therapeutic modalities like proteolysis-targeting chimeras (PROTACs) are being developed to degrade FAK, targeting both its catalytic and scaffolding functions to overcome resistance mechanisms.
ATP-competitive inhibition of the kinase domain, preventing autophosphorylation at Tyr397 and downstream signaling cascades, or degradation of the protein using PROTACs to disrupt both catalytic and scaffolding functions.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Focal adhesion kinase 1 (FAK) (FAK).